Topic: Dementia
Conditions
Interventions
Participants are randomly allocated to one of two groups:
Active iCST group
Each caregiver-participant dyad will receive a 10-week course of Cognitive Stimulation Therapy. This involves completing t
Sponsors
Manchester Mental Health & Social Care Trust
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Caregiver inclusion criteria: 1. Caregiver of a person with PD-MCI, PDD or DLB: Must live with or be carer for someone who has a diagnosis of PDMCI, PDD or DLB 2. Must be well enough to deliver 20 – 30 minute sessions of iCST, two or three times per week Patient inclusion criteria: 1. Must have received a diagnosis of probable PD-MCI, PDD or DLB. Diagnosis will be based on standard clinical diagnostic criteria (Emre et al, 2007; McKeith et al., 2005) determined by the referring clinician and verified by the lead applicant (IL). 2. Must be willing to participate in 20 – 30 minute sessions of iCST, two or three times per week 3. Must be well enough to participate in 20 – 30 minute sessions of iCST, two or three times per week 4. Must be stable on medication regime four weeks prior study entry
Exclusion criteria
Exclusion criteria: Caregiver exclusion criteria: 1. Not a caregiver for someone with PD-MCI, PDD or DLB 2. Cannot understand English or are non-literate 3. Severe physical illness 4. Diagnosis of dementia 5. The person being cared for meets the patient exclusion criteria Patient exclusion criteria: 1. Unwilling to participate in 20 – 30 minute sessions of iCST, two or three times per week 2. Not well enough to participate in 20 – 30 minute sessions of iCST, two or three times per week 3. Caregiver contact less than 3 time per week 4. No caregiver (or caregiver not willing) to deliver therapy and complete study assessments 5. Lives in residential care 6. Cannot understand English or are non-literate 7. Severe physical illness
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| 1. Apathy is measured using the Lille Apathy Rating Scale 2. Caregiver burden is measured using the Zarit Burden Interview | — |
Primary
| Measure | Time frame |
|---|---|
| 1. Quality of life is measured using the Parkinson’s Disease Questionnaire-39 2. Cognitive functioning is measured using the Addenbrook’s Cognitive Examination - Revised Version | — |
Countries
England, United Kingdom
Outcome results
None listed